(Q37998840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

meta-analysis

0 references

title

A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

William G. Honer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Megan Sherwood

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

30 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1175-1184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Early Prediction of Antipsychotic Response in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Duration of untreated psychosis and time to treatment response for delusions and hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Evidence for onset of antipsychotic effects within the first 24 hours of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Methodological issues in current antipsychotic drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Time course of the antipsychotic effect and the underlying behavioral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine in China: a review and preview of US/PRC collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Early onset of treatment effects with oral risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Quetiapine in schizophrenia: onset of action within the first week of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

Clozapine as a first treatment for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112440513

21 January 2018

Identifiers

DOI

10.1177/0269881112440513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22465946%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference